EU agency: Rare blood clots possibly linked to AstraZeneca vaccine
LONDON (AP) — The European Union’s drug regulator says it has found a “possible link” between the AstraZeneca coronavirus vaccine and a rare blood clotting disorder but said that the benefits of the shot still outweigh risks.
In a statement released Wednesday, the European Medicines Agency placed no new restrictions on using the vaccine in people 18 and over.
The EMA said most of the cases reported have occurred in women under 60 within two weeks of vaccination.
The agency said based on the currently available evidence, it was not able to identify specific risk factors.
Experts reviewed several dozen cases that came mainly from Europe and the United Kingdom, where around 25 million people have received the AstraZeneca vaccine.
“The reported cases of unusual blood clotting following vaccination with the AstraZeneca vaccine should be listed as possible side effects of the vaccine,” said Emer Cooke, the agency’s executive director.
Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at email@example.com or firstname.lastname@example.org.